if you take the splits into consideration, well, it would be well above 600 right now. so its gonna split again when it goes 160 sometime next year.
Yes, CELG will grow revenue from around 7B in 2014 to around 17B by 2020. That is 2.5 times what it is worth today.
No I am saying you have no clue. Your numbers prove it. This not about one type of cancer but many. You can say what you want, put your $ where you want, I don't care. I have no time to engage you, and do your DD for you.
So basically your saying you have no clue except of hope and wishful thinking. Every indication combine for both drugs comes out to an addressable market of about 50k people world wide.
I think they intend to do exactly that, this conference would be a good set-up for it. With Gild, PFE, Act, Merck Roche, etc. just flat out buying bio's now at significant valuations, the big bios and pharma's aren't messing around. I think CELG knows this and needs to make a move. I don't know if they have to wait on solid tumor data,, its a plus and minus situation. If they do, the Agio's value is multiples higher than here, and may have to compete with other Co's,, but it's easier to justify to the board and shareholders. if they move now they get it cheaper. Agio may want to wait for solid tumor data to get a higher price, but risk it failing or sell now and not risk it. Maybe there is some antidotal observations they can infer today. We already know the baseline from standard care, if observations are showing solid tumor shrinkage beyond normal, its not a leap to know what is causing it. Going back to the climate of aggressing buying by major pharma's and big bios, I think they have to take a risk now. Agio already has shown stellar data, like throwing a piece of meat in a hog pin, someone is going to make a move.
I was at ASH, went to post conference meetings. Projections were discussed on potential indications, You have to do your own DD, AGIO is very promising for both Co's. This is the one I'd bet on. Good Luck.
OK. you lay out the numbers for me on any of these drugs like AGIO or BLUE. Tell me what they will earn and how much AGIO or BLUE can earn themselves from them?
"CELG is very smart and shrewd.TRUE None of these companies, if they have a big drug, will make much money other then CELG" Hmmm NOT TRUE
I agree. CELG holds no stake in BLUE. It has the standard option to license any of BLUE's products though 2019. If they exercise this right on any drug BLUE will get royalties on world wide sales and 50% of US sales. CELG is very smart and shrewd. None of these companies, if they have a big drug, will make much money other then CELG. Personally I wouldn't own any of them on what they may earn from their drugs since CELG gets the majority of their revenues. I know some people like to play these stories cause the market is irrational and will drive these companies way up to valuations they will never deserve. For my personal speculation, I prefer to stick with companies that still own 100% of their rights. These companies tend to underperform cause they have to issue stock to pay bills, but when they do hit a home run, they are priceless.
CELG does not own any BLUE. But it owns 15% of AGIO, and stakes in OMED, EPZM, Acetylon and many, many others. It's investment portfolio is but one of its greatly under-appreciated assets.
CELG is the Rock Star of biotech. I am buying ahead of Monday. This conference will include 2014 results and forward guidance. CELG will break out to new highs after.
Yes, I told people to buy blue after ASH, It was up a lot then but it has gone up a lot more. Personally I prefer to fiend these companies before the big pops and get out lol.
Celg gives its projection for earnings and profit. This will move the stock up or down depending if the news is good or bad! They will also give progress on their phase two and three trails for certain drugs as well as on Revelmid for MM.
It's a 50-50 whether we are ready to break out above 120. If anything, possibly a double top and then back down. This stock has difficulty consistently moving in the same direction for very long. I own CELG and am
confident that we move higher, but whether we do it this week or next week, I am not so sure. Let's hope you are right and I am wrong.
if CELG is down today I really like buying it here ahead of Mondays JPM healthcare conference. They will be doing a financial update at the conference.